ThinkCareBelieve: The Hunter Biden Pardon and US Biolabs in Ukraine
03. Dezember 2024 13:17 ET
|
ThinkCareBelieve
Washington, DC, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Link to ThinkCareBelieve's Article: https://thinkcarebelieve.blog/2024/12/02/the-hunter-biden-pardon-and-us-biolabs-in-ukraine/ ThinkCareBelieve...
New U.S. Department of Health and Human Services Campaign Joins HBCU Tour to Increase Flu, COVID-19 Vaccinations
10. September 2024 12:21 ET
|
Risk Less. Do More. Pan Respiratory Virus Public Education Campaign
Milwaukee, Wis., Sept. 10, 2024 (GLOBE NEWSWIRE) -- The U.S. Department of Health and Human Services’ (HHS) Risk Less. Do More. campaign is partnering with the HBCU Tailgate Tour to increase...
Politicized Medicine Hindered Use of Ivermectin for COVID, according to the Journal of American Physicians and Surgeons
04. September 2024 11:12 ET
|
Association of American Physicians and Surgeons
The politicized response to Covid included a war on the use of ivermectin. Studies have conflicting results. The issue is at a stalemate.
AB Science annonce des résultats positifs de son étude de Phase 2 évaluant le masitinib dans la Covid-19
08. Juli 2024 01:56 ET
|
AB Science
COMMUNIQUE DE PRESSE AB SCIENCE ANNONCE DES RESULTATS POSITIFS DE SON ETUDE DE PHASE 2 EVALUANT LE MASITINIB DANS LA COVID-19 Paris, 8 juillet 2024, 8h AB Science SA (Euronext - FR0010557264 - AB)...
AB Science announces positive results of its Phase 2 study evaluating masitinib in Covid-19
08. Juli 2024 01:56 ET
|
AB Science
PRESS RELEASE AB SCIENCE REPORTS POSTIVE RESULTS OF ITS PHASE 2 STUDY EVALUATING MASITINIB IN COVID-19 Paris, 8 July 2024, 8am CET AB Science SA (Euronext - FR0010557264 - AB) today announces the...
Revive Therapeutics Provides Update From FDA Meeting for Long COVID Diagnostic Product
10. Juni 2024 07:30 ET
|
Revive Therapeutics Ltd.
TORONTO, June 10, 2024 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research...
Dyadic to Attend Industry Events in June
30. Mai 2024 16:30 ET
|
Dyadic International, Inc.
JUPITER, Fla., May 30, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a biotechnology company focused on the efficient large-scale manufacture of...
Dyadic Reports 2023 Full Year Results and Recent Company Progress
28. März 2024 16:00 ET
|
Dyadic International, Inc.
Closed a $6.0 million convertible note in a private placement, with a conversion price of $1.79 and no warrantsReported positive topline data from First-In-Human Phase 1 trial demonstrated clinical...
Once Esteemed Institutions Are Corrupted, States President of the Association of American Physicians and Surgeons (AAPS)
25. März 2024 10:30 ET
|
Association of American Physicians and Surgeons
Experts and institutions we trusted have been corrupted, and are using their power to silence dissenters. The pandemic response is one of many examples.
electroCore Expands Intellectual Property Portfolio
06. Februar 2024 08:00 ET
|
electroCore, Inc.
ROCKAWAY, N.J., Feb. 06, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced the United States Patent and...